• Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rat...

• Chen Guoliang

• Li Xianlong, Zhu Hongzhang, Wu Huachuan, He Dacheng, Shi Liangyu, Wei Fuxin, Liu Xizhe,&nb...

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1766 ~ 1777

• Single-cell transcriptome analyses reveal distinct gene expression signatures of severe COVID-19 in ...

• Choi Baek-Gyu

• Kang Chang-Kyung, Park Seong-Wan, Lee Do-Hoon, Lee Andrew J., Ko Yu-Ji, Kang Suk-Jo, Kang ...

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1756 ~ 1765

• SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotact...

• Zhang Shaolong

• Zhou Jingping, Shang Pengzhao, Zhao Guomeng, Wang Anlei, Mao Jinlei, Tao Yuhang, Chen Ziyi...

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1741 ~ 1755

• Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TG...

• Xu Yiyang

• Mao Guping, Long Dianbo, Deng Zengfa, Xin Ruobin, Zhang Ziji, Xue Ting, Liao Weiming, ...

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1727 ~ 1740

• AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes i...

• Ghalali Aram

• Wang Liangzhe, Stopsack Konrad H., Rice James M., Wu Shulin, Wu Chin-Lee, Zetter Bruce R., ...

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1713 ~ 1726

• Transcriptional regulation and chromatin dynamics at DNA double-strand breaks

• Min Sun-Woo

• Ji Jae-Hoon, Heo Yun-Gyeong, Cho Hye-Seong

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1705 ~ 1712

• Roles of RIPK3 in necroptosis, cell signaling, and disease

• Morgan Michael J.

• Kim You-Sun

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1695 ~ 1704

• Molecular targeted therapy for anticancer treatment

• Min Hye-Young

• Lee Ho-Young

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1670 ~ 1694

• DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy oppo...

• Abuetabh Yasser

• Wu H. Helena, Chai Chengsen, Al Yousef Habib, Persad Sujata, Sergi Consolato M., Leng Roger

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1658 ~ 1669

• Ferritin ? a multifaceted protein scaffold for biotherapeutics

• Lee Na-Kyeong

• Cho Seongeon, Kim In-San

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1652 ~ 1657

• New insights into the epitranscriptomic control of pluripotent stem cell fate

• Che Young-Hyun

• Lee Ho-Jae, Kim Yong-Jun

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1643 ~ 1651

• 8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification

• Hahm Ja-Young

• Park Jong-Yeun, Jang Eun-Sook, Chi Sung-Wook

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1626 ~ 1642

• The emerging importance of METTL5-mediated ribosomal RNA methylation

• Turkalj Elena M.

• Vissers Caroline

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1617 ~ 1625

• Detection technologies for RNA modifications

• Zhang Yan

• Lu Liang, Li Xiaoyu

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1601 ~ 1616

• Voyages to map unexplored parts of the epitranscriptomic world

• Yoon Ki-Jun

• Experimental & Molecular Medicine   2022  Volume.54  No.10 1599 ~ 1600